This HTML5 document contains 161 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1056/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33408211
rdf:type
wikibase:Item
schema:description
научни чланак bài báo khoa học vetenskaplig artikel мақолаи илмӣ 2013年論文 2013年論文 article scientifique (publié 2013) 2013年论文 artigo científico (publicado na 2013) 2013年論文 wetenschappelijk artikel 2013 թուականի Յունիսին հրատարակուած գիտական յօդուած tudományos cikk vitenskapelig artikkel 2013 թվականի հունիսին հրատարակված գիտական հոդված мақолаи илмӣ 2013年论文 articol științific tieteellinen artikkeli ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ مقالهٔ علمی artigo científico artykuł naukowy научна статия vědecký článek 2013年论文 mokslinis straipsnis 2013年論文 wissenschaftlicher Artikel naučni članak artikull shkencor artigo científico (publicado na 2013) artículu científicu espublizáu en 2013 επιστημονικό άρθρο 2013年論文 научни чланак 2013年论文 سائنسی مضمون наукова стаття, опублікована в червні 2013 article scientific articolo scientifico 2013년 논문 bilimsel makale article científic artículo científico publicado en 2013 2013 nî lūn-bûn scientific article مقالة علمية 2013年の論文 2013年论文 научная статья scienca artikolo სამეცნიერო სტატია teaduslik artikkel บทความทางวิทยาศาสตร์ artikulong pang-agham videnskabelig artikel (udgivet 2013) vitskapeleg artikkel מאמר מדעי 2013年论文 vedecký článok
p:P577
wds:Q33408211-5BE8E290-C352-4C47-9705-C304243BDB0C
wdt:P577
2013-06-01T00:00:00Z
p:P407
wds:Q33408211-3C7F8D24-8D37-421D-8651-2EA1B24B9E87
wdt:P407
wd:Q1860
p:P2093
wds:Q33408211-C79E1FA6-2C21-44C1-92E2-26530BCF707B wds:Q33408211-4BADF4A4-6F23-4F80-A70F-CC57184748E4 wds:Q33408211-4C1CFD89-839A-4DA8-AEC9-7253673F1B96 wds:Q33408211-43C5DDC3-8F82-401A-9628-F2993DBB0C14 wds:Q33408211-3CD45301-2A72-4B3F-9487-ACE1035A3608 wds:Q33408211-391443C5-ED92-4ECB-8089-733B86C95D91 wds:Q33408211-3B429C2A-B83C-4247-BA70-CC2035E947ED wds:Q33408211-7DEC4378-9E3D-471A-83AD-4F119B3B0668 wds:Q33408211-7AF7CE28-6213-4D23-B737-8EB0006A71D5 wds:Q33408211-5ECCE354-2E9A-4A6D-AE90-B2483ABD6C79 wds:Q33408211-605883EA-7EAA-4E00-A6C9-1E212E805B59 wds:Q33408211-5D57351B-968C-4D25-BB4C-02342428CED3 wds:Q33408211-0CBA213B-8C97-4885-ACC5-4BCBED91C6F9 wds:Q33408211-0D8A8F05-3087-4A2F-A4EF-666B52B3240E wds:Q33408211-36F3B57F-9E6A-4817-ACCF-D1B3211B15A8 wds:Q33408211-3134874B-F42A-4F13-8DF3-D8D9AF4039F5 wds:Q33408211-1F15E2D9-6457-41AC-8F39-ABBA66EB0DCA wds:Q33408211-13F76525-9B4B-476A-AC05-BFDABA732055 wds:Q33408211-18C17457-785A-4160-A171-AF71BD4AA74C wds:Q33408211-BB7C2287-C34A-4F34-A7DE-0BFB6A86CAA9 wds:Q33408211-C23111E9-C972-4B88-A61C-D9939B59FEF7 wds:Q33408211-B44E263B-8724-4EC6-8F2B-476F592529E5 wds:Q33408211-97512BF0-015E-41D5-8BF0-DB96529777D8 wds:Q33408211-97884CED-352A-4842-A5A1-1F44699EC929 wds:Q33408211-8E66084A-49B3-4857-A0D6-3A9014006F44 wds:Q33408211-91FB22E2-8B51-44D0-93CD-5EF249028AE2 wds:Q33408211-F134F737-B368-4C0A-99EA-0087A858EA43 wds:Q33408211-EC39AF2A-6C6C-4ACA-8BC7-1561F106A0A4 wds:Q33408211-D9EDE09D-C495-4747-B15A-7B9C13A3446E
wdt:P2093
L B Zimmerhackl A Trivelli T Richard M Herthelius B Moulin C Mariat B Severino R R Furman C Bingham K Douglas O Gaber C Bedrosian S Babu D J Cohen L A Greenbaum M Ogawa T Feldkamp C M Legendre Y Delmas P Muus N S Sheerin R Sberro-Soussan D Fouque C Loirat J Menne M Hourmant J Nürnberger F Eitner C Licht
rdfs:label
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome
skos:prefLabel
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome
schema:name
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome
p:P50
wds:Q33408211-F64EADBF-0008-4902-AB3E-20D71C3288F3 wds:Q33408211-9FE7C3A7-F764-4970-9154-AEF7BA6B5EB7 wds:Q33408211-7C61C84A-081B-4C78-A74F-579189F7C5AB wds:Q33408211-2899C5C5-AF1E-442E-94C6-8C2B0407796F
wdt:P50
wd:Q16561003 wd:Q115122955 wd:Q42887742 wd:Q33292943
p:P1476
wds:Q33408211-F8513045-DC2F-4992-8EF9-271C69A3ED4C
wdt:P1476
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome
p:P304
wds:Q33408211-415E0773-3152-4774-8330-D0D102DBC16E
wdt:P304
2169-2181
p:P31
wds:Q33408211-6585567C-3F89-48D6-9412-192EC4794280
wdt:P31
wd:Q13442814
p:P921
wds:Q33408211-ECF01325-E493-45EE-9E58-C820FB943678
wdt:P921
wd:Q162266
p:P698
wds:Q33408211-CA93830D-FE08-4EB6-BA08-DACE055565EC
wdtn:P698
n11:23738544
wdt:P698
23738544
p:P1433
wds:Q33408211-DF979C74-174E-431D-B0EB-F8F9E7FEE997
wdt:P1433
wd:Q582728
p:P433
wds:Q33408211-3269E1D9-160F-4401-8B74-4E12436362FF
p:P478
wds:Q33408211-FD464EE7-3E71-45E0-A4C2-880E01F69F6E
wdt:P433
23
wdt:P478
368
p:P356
wds:Q33408211-314E7F69-A08E-42EC-A8B4-AFD1D494A9EA
wdtn:P356
n10:NEJMOA1208981
wdt:P356
10.1056/NEJMOA1208981